Lifeclean Q2: Setting the foundation for growth - Redeye

Redeye saw a lower sales development than we expected, while Opex was in line with our estimates. The gross margin was, however, lower. We adjust our estimates slightly downward, primarily based the lower gross margin. We expect this to improve going forward, although the timing is uncertain. The total effect on our Base case value is relatively small as we continue to see a good case for the high-end products in the longer perspective . The reiterated Base case is SEK 9 (9) per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/852310/lifeclean-q222-setting-the-foundation?utm_source=finwire&utm_medium=RSS